From: Cardiac rehabilitation may not provide a quality of life benefit in coronary artery disease patients
 | n | No CR (n = 153) | n | CR (n = 68) |
---|---|---|---|---|
Pre-Angiography Cardioprotective Therapy | ||||
Anti-platelet | 153 | 84% | 68 | 82% |
Beta-blockers | 153 | 35% | 68 | 19% |
Statins | 153 | 67% | 68 | 66% |
ACE-inhibitor | 153 | 42% | 68 | 40% |
Angiotensin Receptor Blocker | 153 | 18% | 68 | 13% |
Obstructive CAD Findings | ||||
Single Vessel Disease | 153 | 29% | 68 | 32% |
Double Vessel Disease | Â | 39% | Â | 32% |
Triple Vessel Disease | Â | 32% | Â | 35% |
Initial Treatment Strategy | ||||
Medical Therapy | 153 | 56% | 68 | 41% |
Coronary Angioplasty/stent | Â | 30% | Â | 43% |
Coronary bypass graft | Â | 14% | Â | 16% |
Seattle Angina Questionnaire | ||||
Physical Limitation | 153 | 54±25 | 68 | 64±22* |
Angina Stability | 153 | 37±31 | 68 | 40±34 |
Angina Frequency | 153 | 59±27 | 68 | 66±27 |
Treatment Satisfaction | 153 | 90±16 | 68 | 89±18 |
Quality of Life | 153 | 42±22 | 68 | 44±24 |
Short-Form 36 | ||||
Physical Summary Score | 153 | 34±11 | 68 | 38±11 |
Mental Summary Score | 153 | 42±11 | 68 | 43±11 |
Elevated Psychosocial Distress | 153 | 62% | 68 | 47%* |